Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone

Blood (2024) 143 (23): 2401–2413.

https://doi.org/10.1182/blood.2023022540

Published: 2024

Includes: Supplemental data

Journal Articles

TP53 and CDKN2A alterations Define a Poor Prognostic Subgroup in Patients with Nodal T-Follicular Helper Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1630.

https://doi.org/10.1182/blood-2023-173638

Published: 2023

Journal Articles

High-Throughput Screening to Elucidate In Vivo Oncogenicity of Loss-of-Function Alterations in Lymphoid Malignancies

Kentaro Yamaguchi, Junji Koya, Kota Mizuno, Kota Yoshifuji, Yuta Ito, Mitsuhiro Yuasa, Yuki Saito, Mariko Tabata, Sumito Shingaki, Yasunori Kogure, Kazutaka Nakashima, Koichi Ohshima, Keisuke Kataoka

Blood (2022) 140 (Supplement 1): 3034–3035.

https://doi.org/10.1182/blood-2022-163203

Published: 2022

Journal Articles

Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma

Yuta Ito, Amira Marouf, Yasunori Kogure, Junji Koya, Mariko Tabata, Yuki Saito, Sumito Shingaki, Mitsuhiro Yuasa, Kentaro Yamaguchi, Julie Bruneau, Manon Vavasseur, Michaël Dussiot, Isabelle Andre, Akshay Joshi, Chantal Lagresle-Peyrou, Aude Magerus, Sammara Chaubard, David Lavergne, Emmanuel Bachy, Erika Brunet, Virginie Fataccioli, Chantal Brouzes, Camille Laurent, Laurence De Leval, Alexandra Traverse-Glehen, Céline Bossard, Marie Parrens, Véronique Meignin, Laure Philippe, Julien Rossignol, Felipe Suarez, Jean-Marie Michot, Olivier Tournilhac, Christine Bole-Feysot, Patrick Nitschke, Bruno Tesson, Cécile Laurent, Thierry Jo Molina, Vahid Asnafi, Sachiko Tsukita, Koji Izutsu, Hiroaki Miyoshi, Seiji Sakata, Akito Dobashi, Kengo Takeuchi, Koichi Ohshima, Philippe Gaulard, Arnaud Jaccard, Seishi Ogawa, Olivier Hermine, Keisuke Kataoka, Lucile Couronne

Blood (2022) 140 (Supplement 1): 1737–1739.

https://doi.org/10.1182/blood-2022-159869

Published: 2022

Journal Articles

Whole-genome landscape of adult T-cell leukemia/lymphoma

Blood (2022) 139 (7): 967–982.

https://doi.org/10.1182/blood.2021013568

Published: 2022

Includes: Supplemental data

Journal Articles

Elucidation of Biological Role and Regulatory Landscape of PD-L2 in B-Cell Lymphoma

Sumito Shingaki, Junji Koya, Mitsuhiro Yuasa, Yuki Saito, Marni B McClure, Mariko Tabata, Kentaro Yamaguchi, Yuta Ito, Yasunori Kogure, Keisuke Kataoka

Blood (2021) 138 (Supplement 1): 714.

https://doi.org/10.1182/blood-2021-150101

Published: 2021

Journal Articles

Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-134360

Published: 2020

Journal Articles

Dissecting Multicellular Ecosystems of HTLV-1 Infection and ATL By Multi-Omics Single Cell Analysis

Junji Koya, MD, Yuki Saito, MD, Takuro Kameda, MD, PhD, Yasunori Kogure, MD PhD, Marni B McClure, MD PhD, Sumito Shingaki, PhD MD, Mariko Tabata, MD, Ayako Kamiunten, MD, Kotaro Shide, MD PhD, Kazuya Shimoda, MD PhD, Keisuke Kataoka, MD PhD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-141755

Published: 2020

Journal Articles

LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells

Tomoyasu Jo, Momoko Nishikori, Yasunori Kogure, Hiroshi Arima, Katsuhiro Sasaki, Yoshiteru Sasaki, Tomoko Nakagawa, Fumie Iwai, Shuji Momose, Aki Shiraishi, Hiroshi Kiyonari, Noritaka Kagaya, Tetsuo Onuki, Kazuo Shin-ya, Minoru Yoshida, Keisuke Kataoka, Seishi Ogawa, Kazuhiro Iwai, Akifumi Takaori-Kondo

Blood (2020) 136 (6): 684–697.

https://doi.org/10.1182/blood.2019002654

Published: 2020

Includes: Supplemental data

Journal Articles

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Toshiaki Takezaki, MD, Akira Honda, MD PhD, Yasunori Kogure, MD PhD, Akira Chiba, MD, Fumihiko Nakamura, MD PhD, Kumi Nakazaki, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5242.

https://doi.org/10.1182/blood-2019-124597

Published: 2019

Journal Articles

Mechanisms Underlying Augmented Lymphomagenesis by LUBAC; Possible Accumulation of AID-Mediated Somatic Mutations

Tomoyasu Jo, MD, Momoko Nishikori, MD PhD, Yoshiteru Sasaki, MD PhD, Yasunori Kogure, MD PhD, Keisuke Kataoka, MD PhD, Seishi Ogawa, MD PhD, Kazuhiro Iwai, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2018) 132 (Supplement 1): 775.

https://doi.org/10.1182/blood-2018-99-111097

Published: 2018

Journal Articles

Novel Mechanism of Post-Transcriptional Regulation of PD-L1 Expression By 3'-UTR Binding Proteins

Yasunori Kogure, MD PhD, Keisuke Kataoka, MD PhD, Shungo Adachi, PhD, Yosaku Watatani, MD, Ayana Kon, MD PhD, Kenichi Yoshida, MD PhD, Masahiro Nakagawa, MD PhD, Tomohisa Hatta, PhD, Tohru Natsume, PhD, Seishi Ogawa, MD PhD

Blood (2017) 130 (Supplement 1): 730.

https://doi.org/10.1182/blood.V130.Suppl_1.730.730

Published: 2017

Journal Articles

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Keisuke Kataoka, MD PhD, Hiroaki Miyoshi, MD PhD, Yasunori Kogure, MD, Yasuharu Sato, MD PhD, Kenji Nishida, MD, Yuichi Shiraishi, PhD, Hiroko Tanaka, BA, Kenichi Chiba, BA, Yosaku Watatani, MD, Yusuke Shiozawa, MD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Motohiro Kato, MD PhD, Satoru Miyano, PhD, Koji Izutsu, MD PhD, Kengo Takeuchi, MD PhD, Tadashi Yoshino, MD PhD, Koichi Ohshima, MD PhD, Seishi Ogawa, MD PhD

Blood (2016) 128 (22): 4105.

https://doi.org/10.1182/blood.V128.22.4105.4105

Published: 2016

Journal Articles

Serum LDH Is Useful to Predict Prognosis for Intermediate-Risk Myelodysplastic Syndrome

Kiyomi Morita, MD, Shunya Arai, MD, PhD, Yasunori Kogure, MD, Akira Honda, MD, Kumi Nakazaki, MD, PhD, Mineo Kurokawa, MD

Blood (2015) 126 (23): 5255.

https://doi.org/10.1182/blood.V126.23.5255.5255

Published: 2015

NARROW

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone

TP53 and CDKN2A alterations Define a Poor Prognostic Subgroup in Patients with Nodal T-Follicular Helper Cell Lymphoma

High-Throughput Screening to Elucidate In Vivo Oncogenicity of Loss-of-Function Alterations in Lymphoid Malignancies

Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma

Whole-genome landscape of adult T-cell leukemia/lymphoma

Elucidation of Biological Role and Regulatory Landscape of PD-L2 in B-Cell Lymphoma

Whole-Genome Analysis of Adult T-Cell Leukemia/Lymphoma

Dissecting Multicellular Ecosystems of HTLV-1 Infection and ATL By Multi-Omics Single Cell Analysis

LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Mechanisms Underlying Augmented Lymphomagenesis by LUBAC; Possible Accumulation of AID-Mediated Somatic Mutations

Novel Mechanism of Post-Transcriptional Regulation of PD-L1 Expression By 3'-UTR Binding Proteins

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Serum LDH Is Useful to Predict Prognosis for Intermediate-Risk Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only